Pfizer

Update in progress

PFE (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Pfizer Inc. discovers, develops, manufactures, and sells biopharmaceuticals worldwide. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company markets medicines across major areas: internal medicine (cardiovascular/metabolic via Eliquis), migraine (Nurtec ODT/Vydura), vaccines (Prevnar family, Abrysvo, Nimenrix, Trumenba), Paxlovid for COVID‑19, inflammation (Xeljanz, Enbrel, Cibinqo), rare diseases, anti‑infectives, oncology, and biosimilars. It collaborates with BMS, Astellas, Merck KGaA, BioNTech, and Boltz.

Company score

Sentiment: 0.07; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -2.12; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.23; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.89; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.84; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.39; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive